(Circulation. 1998;98:2574-2579.)
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports |
Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation
Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT)
From University of California, San Francisco School of Medicine, Fresno, Calif (P.C.D.); Stanford University, Stanford, Calif (P.C.D.); Veterans Affairs Medical Center, Fresno (P.C.D.), Los Angeles (B.N.S.), Richmond (K.E.), and Washington, DC (S.N.S., R.F.); Medical College of Virginia, Richmond (K.E.), and Cooperative Studies Program, Hines, Ill (S.F.).
Correspondence to Prakash C. Deedwania, MD, Cardiology Section, VAMC/UCSF Program, 2615 East Clinton Avenue, Fresno, CA 93703. E-mail deed{at}ucsfresno.edu
Background—In a multicenter, double-blind, placebo-controlled study, the long-term effects of amiodarone on morbidity and mortality in patients with congestive heart failure (CHF) and atrial fibrillation (AF) were evaluated during a 4-year period.
Methods and Results—Of 667 patients with CHF, 103 (15%) had AF
at baseline. Of these, 51 were randomized to amiodarone and 52
to placebo. The group with sinus rhythm and the group in AF were
comparable except for a higher proportion of AF in patients with
nonischemic versus ischemic
cardiomyopathy (41% versus 27%,
P<0.005). The mean ventricular response
(VR) during AF over 24 hours was reduced by amiodarone at 2
weeks (20%, P=0.001), at 6 months (18%,
P=0.001), and at 12 months (16%,
P=0.006). Maximal VR was reduced 22%
(P=0.001) at 2 weeks, 19% (P=0.001) at 6
months, and 14% (P=0.001) at 12 months. Sixteen of 51
patients on amiodarone and 4 of 52 on placebo converted to
sinus rhythm during the study (
2=9.23,
P=0.002). During follow-up, 11 of 268 patients in
sinus rhythm on amiodarone at baseline and 22 of the 263 in
sinus rhythm on placebo developed AF; the difference was significant
(2=12.88, P=0.005). Analysis of
total mortality during follow-up showed a significantly lower mortality
rate (P=0.04) in patients in AF at baseline who
subsequently converted to sinus rhythm on amiodarone than in
those who did not convert to sinus rhythm on the drug.
Conclusions—In patients with CHF, amiodarone has a significant potential to spontaneously convert patients in AF to sinus rhythm, with patients who convert having a lower mortality rate than those who do not. The drug prevented the development of new-onset AF and significantly reduced the VR in those with persistent AF.
Key Words: fibrillation, atrial • heart failure • drugs • survival
This article has been cited by other articles:
 |
|
 |
|
  A. Shotan, M. Garty, D. S. Blondhein, S. R. Meisel, B. S. Lewis, M. Shochat, E. Grossman, A. Porath, V. Boyko, R. Zimlichman, et al. Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS) Eur. Heart J., October 15, 2009; (2009) ehp422v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jhanjee, G. A. Templeton, S. Sattiraju, J. Nguyen, S. Sakaguchi, F. Lu, C. Ermis, S. Milstein, L. Van Heel, K. G. Lurie, et al. Relationship of Paroxysmal Atrial Tachyarrhythmias to Volume Overload: Assessment by Implanted Transpulmonary Impedance Monitoring Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 488 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Caldwell, H. Contractor, S. Petkar, R. Ali, B. Clarke, C. J. Garratt, L. Neyses, and M. A. Mamas Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy Europace, October 1, 2009; 11(10): 1295 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R J Mitchell Is rate more important than rhythm in treating atrial fibrillation? No BMJ, August 21, 2009; 339(aug21_1): b3174 - b3174. [Full Text]
|
|
|
|
|
|
H. Calkins, M. R. Reynolds, P. Spector, M. Sondhi, Y. Xu, A. Martin, C. J. Williams, and I. Sledge Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 349 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R J Shelton, A L Clark, K Goode, A S Rigby, T Houghton, G C Kaye, and J G F Cleland A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study) Heart, June 1, 2009; 95(11): 924 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Anter, M. Jessup, and D. J. Callans Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic Circulation, May 12, 2009; 119(18): 2516 - 2525. [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF]
|
|
|
|
|
|
M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, M. A. Silver, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1343 - 1382. [Full Text] [PDF]
|
|
|
|
|
|
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): 1977 - 2016. [Full Text] [PDF]
|
|
|
|
|
|
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Doyle and K. M. Ho Benefits and Risks of Long-term Amiodarone Therapy for Persistent Atrial Fibrillation: A Meta-analysis Mayo Clin. Proc., March 1, 2009; 84(3): 234 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Coletta, J. G.F. Cleland, D. Cullington, and A. L. Clark Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452 Eur J Heart Fail, September 1, 2008; 10(9): 917 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Roy, M. Talajic, S. Nattel, D. G. Wyse, P. Dorian, K. L. Lee, M. G. Bourassa, J. M. O. Arnold, A. E. Buxton, A. J. Camm, et al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure N. Engl. J. Med., June 19, 2008; 358(25): 2667 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-R. Neuberger, C. Mewis, D. J. van Veldhuisen, U. Schotten, I. C. van Gelder, M. A. Allessie, and M. Bohm Management of atrial fibrillation in patients with heart failure Eur. Heart J., November 1, 2007; 28(21): 2568 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vassallo and R. G. Trohman Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications JAMA, September 19, 2007; 298(11): 1312 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. N. Singh and E. Aliot Newer antiarrhythmic agents for maintaining sinus rhythm in atrial fibrillation: simplicity or complexity? Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G17 - G25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. De Ferrari, C. Klersy, P. Ferrero, C. Fantoni, D. Salerno-Uriarte, L. Manca, P. Devecchi, G. Molon, M. Revera, A. Curnis, et al. Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry Eur J Heart Fail, May 1, 2007; 9(5): 502 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C. Van Gelder and M. E.W. Hemels The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm Europace, November 1, 2006; 8(11): 943 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]
|
|
|
|
|
|
A. A. Elesber, A. G. Rosales, R. M. Herges, W.-K. Shen, B. S. Moon, J. F. Malouf, N. M. Ammash, V. Somers, D. O. Hodge, B. J. Gersh, et al. Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly Eur. Heart J., April 1, 2006; 27(7): 854 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. N. Singh {beta}-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4_suppl): S3 - S14. [Abstract] [PDF]
|
|
|
|
|
|
A. Verma, A. Natale, B. J. Padanilam, E. N. Prystowsky, A. Verma, A. Natale, B. J. Padanilam, and E. N. Prystowsky Why Atrial Fibrillation Ablation Should Be Considered First-Line Therapy for Some Patients Circulation, August 23, 2005; 112(8): 1214 - 1222. [Full Text] [PDF]
|
|
|
|
|
|
J. H.K. Vogel, S. F. Bolling, R. B. Costello, E. M. Guarneri, M. W. Krucoff, J. C. Longhurst, B. Olshansky, K. R. Pelletier, C. M. Tracy, R. A. Vogel, et al. Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) J. Am. Coll. Cardiol., July 5, 2005; 46(1): 184 - 221. [Full Text] [PDF]
|
|
|
|
|
|
K. Swedberg, L. G. Olsson, A. Charlesworth, J. Cleland, P. Hanrath, M. Komajda, M. Metra, C. Torp-Pedersen, and P. Poole-Wilson Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET Eur. Heart J., July 1, 2005; 26(13): 1303 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zimetbaum An Argument for Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation Circulation, June 14, 2005; 111(23): 3150 - 3156. [Full Text] [PDF]
|
|
|
|
|
|
B. N. Singh, S. N. Singh, D. J. Reda, X. C. Tang, B. Lopez, C. L. Harris, R. D. Fletcher, S. C. Sharma, J. E. Atwood, A. K. Jacobson, et al. Amiodarone versus Sotalol for Atrial Fibrillation N. Engl. J. Med., May 5, 2005; 352(18): 1861 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lehto, S. Snapinn, K. Dickstein, K. Swedberg, M. S. Nieminen, and on behalf of the OPTIMAAL investigators Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience Eur. Heart J., February 2, 2005; 26(4): 350 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-F. Hsu, P. Jais, P. Sanders, S. Garrigue, M. Hocini, F. Sacher, Y. Takahashi, M. Rotter, J.-L. Pasquie, C. Scavee, et al. Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure N. Engl. J. Med., December 2, 2004; 351(23): 2373 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Cha, M. M. Redfield, W.-K. Shen, and B. J. Gersh Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle Circulation, June 15, 2004; 109(23): 2839 - 2843. [Full Text] [PDF]
|
|
|
|
|
|
T. Deneke, T. Lawo, B. Gerritse, B. Lemke, and for the European GEM DRTM Investigators Mortality of patients with implanted cardioverter/defibrillators in relation to episodes of atrial fibrillation Europace, January 1, 2004; 6(2): 151 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography Ann Intern Med, December 16, 2003; 139(12): 1018 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. U. Khand, A. C. Rankin, W. Martin, J. Taylor, I. Gemmell, and J. G. F. Cleland Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1944 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Tejan-Sie, R. D. Murray, I. W. Black, S. E. Jasper, C. Apperson-Hansen, J. Li, E. A. Lieber, R. A. Grimm, A. L. Klein, and ACUTE Investigators Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: An ACUTE trial ancillary study J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1638 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Galperin, M. V. Elizari, P. A. Chiale, R. T. Molina, R. Ledesma, A. O. Scapin, M. V. Blanco, R. Bonato, M. Lago, and Grupo de Estudio de Fibrilacion Auricular Con Amio Pharmacologic Reversion of Persistent Atrial Fibrillation with Amiodarone Predicts Long-Term Sinus Rhythm Maintenance Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 179 - 186. [Abstract] [PDF]
|
|
|
|
|
|
A. Capucci and D. Aschieri Antiarrhythmic drug therapy: what is certain and what is to come Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H8 - H18. [Abstract] [PDF]
|
|
|
|
|
|
T. J. Wang, M. G. Larson, D. Levy, R. S. Vasan, E. P. Leip, P. A. Wolf, R. B. D'Agostino, J. M. Murabito, W. B. Kannel, and E. J. Benjamin Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study Circulation, June 17, 2003; 107(23): 2920 - 2925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Gronefeld and S. H. Hohnloser Heart Failure Complicated by Atrial Fibrillation: Mechanistic, Prognostic, and Therapeutic Implications Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 107 - 113. [Abstract] [PDF]
|
|
|
|
|
|
I. Savelieva and A. John Camm Atrial fibrillation and heart failure: natural history and pharmacological treatment Europace, January 1, 2003; 5(s1): S5 - S19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Blaauw, I C Van Gelder, and H J G M Crijns Treatment of atrial fibrillation Heart, October 1, 2002; 88(4): 432 - 437. [Full Text] [PDF]
|
|
|
|
|
|
S.R. Raj and D.G. Wyse Rhythm control for paroxysmal atrial fibrillation after AV junction ablation: is it worth the effort? Eur. Heart J., June 1, 2002; 23(11): 845 - 848. [Full Text] [PDF]
|
|
|
|
|
|
M. Brignole, C. Menozzi, M. Gasparini, M. G. Bongiorni, G.L. Botto, R. Ometto, P. Alboni, C. Bruna, A. Vincenti, and R. Verlato An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation Eur. Heart J., June 1, 2002; 23(11): 892 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Galperin, M. V. Elizari, P. A. Chiale, R. T. Molina, R. Ledesma, A. O. Scapin, and M. V. Blanco Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 341 - 350. [Abstract] [PDF]
|
|
|
|
|
|
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF]
|
|
|
|
|
|
J.G.F. Cleland, K. Thygesen, B.F. Uretsky, P. Armstrong, J.D. Horowitz, B. Massie, M. Packer, P.A. Poole-Wilson, L. Ryden, and on behalf of the ATLAS investigators Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study Eur. Heart J., September 1, 2001; 22(17): 1601 - 1612. [Abstract] [PDF]
|
|
|
|
|
|
O. D. Pedersen, H. Bagger, N. Keller, B. Marchant, L. Kober, and C. Torp-Pedersen Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy Circulation, July 17, 2001; 104(3): 292 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Azpitarte, O. Baun, E. Moreno, R. Garcia-Orta, J. Sanchez-Ramos, and L. Tercedor In Patients With Chronic Atrial Fibrillation and Left Ventricular Systolic Dysfunction, Restoration of Sinus Rhythm Confers Substantial Benefit Chest, July 1, 2001; 120(1): 132 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.U Khand, I Gemmell, A.C Rankin, and J.G.F Cleland Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges Eur. Heart J., January 2, 2001; 22(2): 153 - 164. [Abstract] [PDF]
|
|
|
|
|
|
H.J.G.M Crijns, G Tjeerdsma, P.J de Kam, F Boomsma, I.C van Gelder, M.P van den Berg, and D.J van Veldhuisen Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure Eur. Heart J., August 1, 2000; 21(15): 1238 - 1245. [Abstract] [PDF]
|
|
|
|
 |
|
 S.-H. Lee, C.-M. Chang, M.-J. Lu, R.-J. Lee, J.-J. Cheng, C.-R. Hung, and S.-A. Chen Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting Ann. Thorac. Surg., July 1, 2000; 70(1): 157 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland Systematic review of the management of atrial fibrillation in patients with heart failure Eur. Heart J., April 2, 2000; 21(8): 614 - 632. [Abstract] [PDF]
|
|
|
|
|
|
S. H. Hohnloser, Y.-G. Li, B. Bender, and G. Gronefeld Review : Pharmacological Management of Atrial Fibrillation: An Update Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(1): 11 - 16. [Abstract] [PDF]
|
|
|
|
|
|
S. J. Connolly Evidence-Based Analysis of Amiodarone Efficacy and Safety Circulation, November 9, 1999; 100(19): 2025 - 2034. [Full Text] [PDF]
|
|
|
|
 |
|
 O M P JOLOBE;, Y. KREISS, Y. SIDI, and H. GUR Amiodarone in atrial fibrillation Postgrad. Med. J., November 1, 1999; 75(889): 703a - 703. [Full Text]
|
|
|
|
|
|
C. Torp-Pedersen, M. Moller, P. E. Bloch-Thomsen, L. Kober, E. Sandoe, K. Egstrup, E. Agner, J. Carlsen, J. Videbak, B. Marchant, et al. Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction N. Engl. J. Med., September 16, 1999; 341(12): 857 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Stevenson and L. W. Stevenson Atrial Fibrillation in Heart Failure N. Engl. J. Med., September 16, 1999; 341(12): 910 - 911. [Full Text]
|
|
|
|
 |
|
 Amiodarone Restores and Maintains Sinus Rhythm in CHF Patients with AF Journal Watch Emergency Medicine, February 1, 1999; 1999(201): 6 - 6. [Full Text]
|
|